As of December 2025 Blueprint Medicines has a market cap of $8.37 Billion USD. This makes Blueprint Medicines the world's 2202th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.